Funding
← Back to your selection

Fairmount

Activity from announced rounds

All recorded activity
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$425M
2 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1

By primary sector

Biotech2

By country

United States2

Rounds

2 in all activity
Mirador Therapeutics

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

$250MSeries B
Role not disclosed